Literature DB >> 15326152

RS-1 Gene Delivery to an Adult Rs1h Knockout Mouse Model Restores ERG b-Wave with Reversal of the Electronegative Waveform of X-Linked Retinoschisis.

Yong Zeng1, Yuichiro Takada, Sten Kjellstrom, Kelaginamane Hiriyanna, Atsuhiro Tanikawa, Eric Wawrousek, Nizar Smaoui, Rafael Caruso, Ronald A Bush, Paul A Sieving.   

Abstract

PURPOSE: To create and evaluate a mouse model of human X-linked juvenile retinoschisis (XLRS) and then investigate whether supplementing with the retinoschisin protein by gene delivery can reverse the abnormal "electronegative" electroretinogram (ERG) retinal response.
METHODS: An X-linked retinoschisis mouse (Rs1h-KO) model was created by substituting a neomycin resistance cassette for exon 1 and 1.6 kb of intron 1 of Rs1h, the murine orthologue of the human RS-1 gene. RS protein was evaluated by immunohistochemistry and Western blot analysis with a polyclonal RS N-terminus antibody. Retinal function was evaluated by conventional, full-field flash ERG recordings. RS protein supplementation therapy was evaluated by gene transfer with an AAV(2/2)-CMV-Rs1h vector containing C57BL/6J Rs1h cDNA under the regulation of a CMV promoter, and ERG functional analysis was performed.
RESULTS: No RS protein was detected by Western blot analysis or immunohistochemistry in the Rs1h-KO mouse. Dark-adapted ERG responses showed an electronegative configuration, with b-wave reduction in both Rs1h(-/Y) and Rs1h-/- mice, typical of XLRS in humans. Histologic examination of Rs1h-KO mice showed disorganization of multiple retinal layers, including duplication and mislocalization of ganglion cells, laminar dissection through the inner plexiform layer, disorganization of the outer plexiform layer, loss of regularity of the outer nuclear layer, and shortening of the inner/outer segments with mislocalization of photoreceptor nuclei into this layer. After intraocular administration of AAV(2/2)-CMV-Rs1h, immunohistochemistry showed retinoschisin expression in all retinal layers of Rs1h(-/Y) mice, and ERG recordings showed reversal of the electronegative waveform and restoration of the normal positive b-wave.
CONCLUSIONS: The RS-KO mouse mimics structural features of human X-linked juvenile retinoschisis with dissection through, and disorganization of, multiple retinal layers. The Rs1h-KO functional deficit results in an electronegative ERG waveform that is characteristic of human retinoschisis disease and that implicates a synaptic transmission deficit in the absence of retinoschisin protein. Replacement therapy by supplementing normal Rs1h protein in the adult Rs1h-KO mouse restored the normal ERG configuration. This indicates that gene therapy is a viable strategy of therapeutic intervention even in the postdevelopmental adult stage of XLRS disease. Copyright Association for Research in Vision and Ophthalmology

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15326152     DOI: 10.1167/iovs.04-0576

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  83 in total

Review 1.  AAV-mediated gene therapy in mouse models of recessive retinal degeneration.

Authors:  J-J Pang; L Lei; X Dai; W Shi; X Liu; A Dinculescu; J H McDowell
Journal:  Curr Mol Med       Date:  2012-03       Impact factor: 2.222

2.  Molecular pathology of X linked retinoschisis: mutations interfere with retinoschisin secretion and oligomerisation.

Authors:  T Wang; A Zhou; C T Waters; E O'Connor; R J Read; D Trump
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

Review 3.  A review of in vivo animal studies in retinal prosthesis research.

Authors:  Dimiter R Bertschinger; Evgueny Beknazar; Manuel Simonutti; Avinoam B Safran; José A Sahel; Serge G Rosolen; Serge Picaud; Joel Salzmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-08-16       Impact factor: 3.117

4.  Characterization and purification of the discoidin domain-containing protein retinoschisin and its interaction with galactose.

Authors:  Frank M Dyka; Winco W H Wu; Tom A Pfeifer; Laurie L Molday; Thomas A Grigliatti; Robert S Molday
Journal:  Biochemistry       Date:  2008-08-09       Impact factor: 3.162

Review 5.  Gene therapy and genome surgery in the retina.

Authors:  James E DiCarlo; Vinit B Mahajan; Stephen H Tsang
Journal:  J Clin Invest       Date:  2018-06-01       Impact factor: 14.808

6.  Circadian regulation of retinoschisin in the chick retina.

Authors:  Michael L Ko; Yilin Liu; Liheng Shi; Dorothy Trump; Gladys Y-P Ko
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

7.  Mouse models of X-linked juvenile retinoschisis have an early onset phenotype, the severity of which varies with genotype.

Authors:  Yang Liu; Junzo Kinoshita; Elena Ivanova; Duo Sun; Hong Li; Tara Liao; Jingtai Cao; Brent A Bell; Jacob M Wang; Yajun Tang; Susannah Brydges; Neal S Peachey; Botir T Sagdullaev; Carmelo Romano
Journal:  Hum Mol Genet       Date:  2019-09-15       Impact factor: 6.150

8.  Retinoschisin (RS1) interacts with negatively charged lipid bilayers in the presence of Ca2+: an atomic force microscopy study.

Authors:  Svetlana Kotova; Camasamudram Vijayasarathy; Emilios K Dimitriadis; Laertis Ikonomou; Howard Jaffe; Paul A Sieving
Journal:  Biochemistry       Date:  2010-08-24       Impact factor: 3.162

9.  Retinoschisin, a new binding partner for L-type voltage-gated calcium channels in the retina.

Authors:  Liheng Shi; Kuihuan Jian; Michael L Ko; Dorothy Trump; Gladys Y-P Ko
Journal:  J Biol Chem       Date:  2008-12-11       Impact factor: 5.157

10.  Synaptic pathology in retinoschisis knockout (Rs1-/y) mouse retina and modification by rAAV-Rs1 gene delivery.

Authors:  Yuichiro Takada; Camasamudram Vijayasarathy; Yong Zeng; Sten Kjellstrom; Ronald A Bush; Paul A Sieving
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.